April Watkins
Adult Health · Seattle, WANPI 1659689941
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,981 of the $101,221 with a category attached, or 66.2%. Novo Nordisk accounts for 91.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $63,416 and has fallen 52.9% since, to $29,856 in 2025. Among adult health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $632.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$92K
- Biosense Webster, Inc.$4K
- Boston Scientific$2K
- Atricure, Inc.$2K
- Medtronic$808
- Abbott$323
- plus $713 from 6 others
What the payments were for
- Consulting fees$3,5003%
- Speaking & faculty fees$66,98166%
- Travel & lodging$23,88924%
- Food & beverage$6,7557%
- Education$970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 114 | $92,193 |
| Biosense Webster, Inc. | 2 | $3,586 |
| Boston Scientific | 12 | $1,815 |
| Atricure, Inc. | 15 | $1,784 |
| Medtronic | 8 | $808 |
| Abbott | 2 | $323 |
| Boehringer Ingelheim | 2 | $215 |
| AstraZeneca | 1 | $132 |
| Inspire Medical Systems, Inc. | 1 | $111 |
| E.r. Squibb & Sons, L.L.C. | 1 | $101 |
| Amgen | 1 | $81 |
| Impulse Dynamics (USA) Inc. | 1 | $71 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$42,805
- Carto 3$3,500
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,509
- Ozempic$500
- Micra$347
- Saxenda$237
- ADVISOR$171
- ENSITE PRECISION$151
- WATCHMAN Access System$148
- ATRICLIP LAA EXCLUSION SYSTEM$146
- FARXIGA$132
- ADVISA DR MRI SURESCAN$130
- Inspire$111
- AFFERA MAPPING SYSTEM$103
- CAMZYOS$101
How this compares
$101,221 in reported general payments places this provider in the 95th percentile of 252 adult health providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 106 | $110,354 |
| XareltoRivaroxaban | 24 | $23,055 |
| Flecainide Acetate | 26 | $1,638 |
| Amiodarone Hcl | 79 | $829 |
| Metoprolol Succinate | 65 | $490 |
| Ranolazine ErRanolazine | 14 | $295 |
| Carvedilol | 19 | $224 |
| SotalolSotalol Hcl | 32 | $217 |
| Potassium Chloride | 13 | $170 |
| ClopidogrelClopidogrel Bisulfate | 13 | $65 |
| Furosemide | 22 | $59 |
Paid to pharmacies, not to this prescriber.
Other adult health in Seattle
- George BaxterSeattle$868K
- Leslie SwansonSeattle$18K
- Kindra Clark-SnustadSeattle$10K
- Parminder MinhasSeattle$4K
- Zachary AnnenSeattle$4K
- Erika OrbanSeattle$3K
- Jessica LeibeltSeattle$3K
- Teresa Gegax-MartinezSeattle$2K
- Denise MitchellSeattle$2K
- Alvin AceronSeattle$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.